Abstract
Cancer is a collection of diseases caused by specific changes at the genomic level that support cell proliferation indefinitely. Traditionally, ion channels are known to control a variety of cellular processes including electrical signal generation and transmission, secretion, and contraction by controlling ionic gradients. However, recent studies had brought to light important facts on ion channels in cancer biology.
In this review we discuss the mechanism linking potassium or chloride ion channel activity to biochemical pathways controlling proliferation in cancer cells and the potential advantages of targeting ion channels as an anticancer therapeutic option.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AVD:
-
Apoptotic volume decrease
- ER/PR:
-
Estrogen/progesterone receptors
- GPER:
-
G protein estrogen receptor
- HER2:
-
Human epidermal growth factor receptor 2
- K2P:
-
Two-pore-domain potassium channel
- Kir:
-
Inward-rectifier potassium channel
- Kv:
-
Voltage-gated potassium channel
- LRRC:
-
Leucine-rich repeat-containing
- Vm:
-
Voltage membrane
- VRAC:
-
Volume regulated anion channels
References
Accardi A (2015) Cell signaling. Lipids link ion channels and cancer. Science 349(6250):789–790
Agarwal JR, Griesinger F, Stuhmer W, Pardo LA (2010) The potassium channel ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Mol Cancer 9:18
Albertson DG (2006) Gene amplification in cancer. Trends Genet 22(8):447–455
Ali NA, Wu J, Hochgrafe F, Chan H, Nair R, Ye S et al (2014) Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways. Breast Cancer Res 16(5):437
Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B et al (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26(4):435–439
Baffy G (2010) Uncoupling protein-2 and cancer. Mitochondrion 10(3):243–252
Baffy G, Derdak Z, Robson SC (2011) Mitochondrial recoupling: a novel therapeutic strategy for cancer? Br J Cancer 105(4):469–474
Banderali U, Ehrenfeld J (1996) Heterogeneity of volume-sensitive chloride channels in basolateral membranes of A6 epithelial cells in culture. J Membr Biol 154(1):23–33
Banderali U, Roy G (1992) Anion channels for amino-acids in Mdck cells. Am J Physiol 263(6):C1200–C1207
Banderali U, Jayanthan A, Hoeksema KA, Narendran A, Giles WR (2012) Ion channels in pediatric CNS atypical teratoid/rhabdoid tumor (AT/RT) cells: potential targets for novel therapeutic agents. J Neurooncol 107(1):111–119
Bentzen BH, Bahrke S, Wu K, Larsen AP, Odening KE, Franke G et al (2011) Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits. J Cardiovasc Pharmacol 57(2):223–230
Bianchi L, Wible B, Arcangeli A, Taglialatela M, Morra F, Castaldo P et al (1998) Herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res 58(4):815–822
Biasutto L, Azzolini M, Szabo I, Zoratti M (2016) The mitochondrial permeability transition pore in AD 2016: an update. Biochim Biophys Acta 1863(10):2515–2530
Bill A, Gutierrez A, Kulkarni S, Kemp C, Bonenfant D, Voshol H et al (2015) ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer. Oncotarget 6(11):9173–9188
Binggeli R, Weinstein RC (1986) Membrane potentials and sodium channels: hypotheses for growth regulation and cancer formation based on changes in sodium channels and gap junctions. J Theor Biol 123(4):377–401
Boonstra J, Mummery CL, Tertoolen LG, Van Der Saag PT, De Laat SW (1981) Cation transport and growth regulation in neuroblastoma cells. Modulations of K+ transport and electrical membrane properties during the cell cycle. J Cell Physiol 107(1):75–83
Brevet M, Haren N, Sevestre H, Merviel P, Ouadid-Ahidouch H (2009a) DNA methylation of K(v)1.3 potassium channel gene promoter is associated with poorly differentiated breast adenocarcinoma. Cell Physiol Biochem 24(1–2):25–32
Brevet M, Fucks D, Chatelain D, Regimbeau JM, Delcenserie R, Sevestre H et al (2009b) Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas 38(6):649–654
Bulk E, Ay AS, Hammadi M, Ouadid-Ahidouch H, Schelhaas S, Hascher A et al (2015) Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer. Int J Cancer 137(6):1306–1317
Chernet BT, Levin M (2013) Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model. Dis Model Mech 6(3):595–607
Choe S (2002) Potassium channel structures. Nat Rev Neurosci 3(2):115–121
Cicek MS, Koestler DC, Fridley BL, Kalli KR, Armasu SM, Larson MC et al (2013) Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel. Hum Mol Genet 22(15):3038–3047
Cone CD Jr (1969) Electroosmotic interactions accompanying mitosis initation in sarcoma cells in vitro. Trans N Y Acad Sci 31(4):404–427
Cone CD Jr (1970) Variation of the transmembrane potential level as a basic mechanism of mitosis control. Oncology 24(6):438–470
Cone CD Jr (1971) Unified theory on the basic mechanism of normal mitotic control and oncogenesis. J Theor Biol 30(1):151–181
Crociani O, Guasti L, Balzi M, Becchetti A, Wanke E, Olivotto M et al (2003) Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem 278(5):2947–2955
DeCoursey TE, Chandy KG, Gupta S, Cahalan MD (1984) Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature 307(5950):465–468
Delierneux C, Kouba S, Shanmughapriya S, Potier-Cartereau M, Trebak M, Hempel N (2020) Mitochondrial calcium regulation of redox signaling in cancer. Cells (2):9
Djamgoz MBA, Mycielska M, Madeja Z, Fraser SP, Korohoda W (2001) Directional movement of rat prostate cancer cells in direct-current electric field: involvement of voltagegated Na+ channel activity. J Cell Sci 114(Pt 14):2697–2705
Du S, Yang L (2015) ClC-3 chloride channel modulates the proliferation and migration of osteosarcoma cells via AKT/GSK3beta signaling pathway. Int J Clin Exp Pathol 8(2):1622–1630
Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H et al (2007) Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem 282(15):11221–11229
Fujimoto M, Inoue T, Kito H, Niwa S, Suzuki T, Muraki K et al (2017) Transcriptional repression of HER2 by ANO1 Cl(−) channel inhibition in human breast cancer cells with resistance to trastuzumab. Biochem Biophys Res Commun 482(1):188–194
Fukushiro-Lopes DF, Hegel AD, Rao V, Wyatt D, Baker A, Breuer EK et al (2018) Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer. Oncotarget 9(3):3321–3337
Fukushiro-Lopes D, Hegel AD, Russo A, Senyuk V, Liotta M, Beeson GC et al (2020) Repurposing Kir6/SUR2 channel activator minoxidil to arrests growth of gynecologic cancers. Front Pharmacol 11:577
Gentile S (2012) Ion channel phosphorylopathy: a link between genomic variation and human disease. ChemMedChem 7(10):1757–1761
Gentile S (2016) hERG1 potassium channel in cancer cells: a tool to reprogram immortality. Eur Biophys J 45(7):649–655
Gentile S, Darden T, Erxleben C, Romeo C, Russo A, Martin N et al (2006) Rac GTPase signaling through the PP5 protein phosphatase. Proc Natl Acad Sci U S A 103(13):5202–5206
Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M et al (2013) Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 110(15):5887–5892
Godse NR, Khan N, Yochum ZA, Gomez-Casal R, Kemp C, Shiwarski DJ et al (2017) TMEM16A/ANO1 inhibits apoptosis via downregulation of Bim expression. Clin Cancer Res 23(23):7324–7332
Gomez-Varela D, Zwick-Wallasch E, Knotgen H, Sanchez A, Hettmann T, Ossipov D et al (2007) Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 67(15):7343–7349
Goswami C, Hucho T (2007) TRPV1 expression-dependent initiation and regulation of filopodia. J Neurochem 103(4):1319–1333
Grasso D, Zampieri LX, Capeloa T, Van de Velde JA, Sonveaux P (2020) Mitochondria in cancer. Cell Stress 4(6):114–146
Gray LS, Perez-Reyes E, Gomora JC, Haverstick DM, Shattock M, McLatchie L et al (2004) The role of voltage gated T-type Ca2+ channel isoforms in mediating “capacitative” Ca2+ entry in cancer cells. Cell Calcium 36(6):489–497
Grimm C, Bartel K, Vollmar AM, Biel M (2018) Endolysosomal cation channels and cancer – a link with great potential. Pharmaceuticals (Basel) 11(1)
Guan LZ, Song Y, Gao J, Gao JJ, Wang KW (2016) Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells. Oncotarget 7(48):78619–78630
Hartung F, Kruwel T, Shi X, Pfizenmaier K, Kontermann R, Chames P et al (2020) A novel anti-Kv10.1 nanobody fused to single-chain TRAIL enhances apoptosis induction in cancer cells. Front Pharmacol 11:686
Hegle AP, Marble DD, Wilson GF (2006) A voltage-driven switch for ion-independent signaling by ether-a-go-go K+ channels. Proc Natl Acad Sci U S A 103(8):2886–2891
Hoffmann EK, Lambert IH (2014) Ion channels and transporters in the development of drug resistance in cancer cells. Philos Trans R Soc Lond B Biol Sci 369(1638):20130109
Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N et al (2014) Drug resistance in cancer: an overview. Cancers (Basel) 6(3):1769–1792
Iitaka D, Shiozaki A, Ichikawa D, Kosuga T, Komatsu S, Okamoto K et al (2012) Blockade of chloride ion transport enhances the cytocidal effect of hypotonic solution in gastric cancer cells. J Surg Res 176(2):524–534
Innamaa A, Jackson L, Asher V, Van Shalkwyk G, Warren A, Hay D et al (2013) Expression and prognostic significance of the oncogenic K2P potassium channel KCNK9 (TASK-3) in ovarian carcinoma. Anticancer Res 33(4):1401–1408
Jentsch TJ, Lutter D, Planells-Cases R, Ullrich F, Voss FK (2016) VRAC: molecular identification as LRRC8 heteromers with differential functions. Pflugers Archiv Eur J Physiol 468(3):385–393
Jia LH, Liu W, Guan LZ, Lu M, Wang KW (2015) Inhibition of calcium-activated chloride channel ANO1/TMEM16A suppresses tumor growth and invasion in human lung cancer. Plos One 10(8)
Johnstone BM (1959) Micro-electrode penetration of ascites tumour cells. Nature 183(4658):411
Kaczorowski GJ, McManus OB, Priest BT, Garcia ML (2008) Ion channels as drug targets: the next GPCRs. J Gen Physiol 131(5):399–405
Kapur N, Mignery GA, Banach K (2007) Cell cycle-dependent calcium oscillations in mouse embryonic stem cells. Am J Physiol Cell Physiol 292(4):C1510–C1518
Kischel P, Girault A, Rodat-Despoix L, Chamlali M, Radoslavova S, Abou Daya H et al (2019) Ion channels: new actors playing in chemotherapeutic resistance. Cancers (Basel) 11(3)
Koster AK, Wood CAP, Thomas-Tran R, Chavan TS, Almqvist J, Choi KH et al (2018) A selective class of inhibitors for the CLC-Ka chloride ion channel. Proc Natl Acad Sci U S A 115(21):E4900–E49E9
Kudou M, Shiozaki A, Kosuga T, Ichikawa D, Konishi H, Morimura R et al (2016) Inhibition of regulatory volume decrease enhances the cytocidal effect of hypotonic shock in hepatocellular carcinoma. J Cancer 7(11):1524–1533
Lallet-Daher H, Wiel C, Gitenay D, Navaratnam N, Augert A, Le Calve B et al (2013) Potassium channel KCNA1 modulates oncogene-induced senescence and transformation. Cancer Res 73(16):5253–5265
Lansu K, Gentile S (2013) Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program. Cell Death Dis 4:e652
Leanza L, Henry B, Sassi N, Zoratti M, Chandy KG, Gulbins E et al (2012) Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med 4(7):577–593
Leanza L, Trentin L, Becker KA, Frezzato F, Zoratti M, Semenzato G et al (2013) Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. Leukemia 27(8):1782–1785
Leanza L, Venturini E, Kadow S, Carpinteiro A, Gulbins E, Becker KA (2015) Targeting a mitochondrial potassium channel to fight cancer. Cell Calcium 58(1):131–138
Leanza L, Manago A, Zoratti M, Gulbins E, Szabo I (2016) Pharmacological targeting of ion channels for cancer therapy: In vivo evidences. Biochim Biophys Acta 1863(6 Pt B):1385–1397
Leanza L, Romio M, Becker KA, Azzolini M, Trentin L, Manago A et al (2017) Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo. Cancer Cell 31(4):516–531.e10
Lepple-Wienhues A, Berweck S, Bohmig M, Leo CP, Meyling B, Garbe C et al (1996) K+ channels and the intracellular calcium signal in human melanoma cell proliferation. J Membr Biol 151(2):149–157
Levin M (2012) Molecular bioelectricity in developmental biology: new tools and recent discoveries: control of cell behavior and pattern formation by transmembrane potential gradients. Bioessays 34(3):205–217
Levin M (2014) Molecular bioelectricity: how endogenous voltage potentials control cell behavior and instruct pattern regulation in vivo. Mol Biol Cell 25(24):3835–3850
Li M, Wu DB, Wang J (2013) Effects of volume-activated chloride channels on the invasion and migration of human endometrial cancer cells. Eur J Gynaecol Oncol 34(1):60–64
Lobikin M, Chernet B, Lobo D, Levin M (2012) Resting potential, oncogene-induced tumorigenesis, and metastasis: the bioelectric basis of cancer in vivo. Phys Biol 9(6):065002
Loibl S, Marme F, Martin M, Untch M, Bonnefoi H, Kim SB et al (2021) Palbociclib for residual high-risk invasive HR-positive and HER2-negative early breast cancer-the penelope-B trial. J Clin Oncol:JCO2003639
Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B (2017) The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 7(3):339–348
Mao JW, Yuan J, Wang LW, Zhang HF, Jin XB, Zhu JY et al (2013) Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current. J Cell Physiol 228(5):991–1001
Marino AA, Morris DM, Schwalke MA, Iliev IG, Rogers S (1994) Electrical potential measurements in human breast cancer and benign lesions. Tumour Biol 15(3):147–152
Menendez ST, Villaronga MA, Rodrigo JP, Alvarez-Teijeiro S, Garcia-Carracedo D, Urdinguio RG et al (2012a) Frequent aberrant expression of the human ether a go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications. J Mol Med (Berl) 90(10):1173–1184
Menendez ST, Rodrigo JP, Alvarez-Teijeiro S, Villaronga MA, Allonca E, Vallina A et al (2012b) Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas. Mod Pathol 25(8):1069–1078
Morais Cabral JH, Lee A, Cohen SL, Chait BT, Li M, Mackinnon R (1998) Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain. Cell 95(5):649–655
Morokuma J, Blackiston D, Adams DS, Seebohm G, Trimmer B, Levin M (2008) Modulation of potassium channel function confers a hyperproliferative invasive phenotype on embryonic stem cells. Proc Natl Acad Sci U S A 105(43):16608–16613
Mu D, Chen L, Zhang X, See LH, Koch CM, Yen C et al (2003) Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3(3):297–302
Munaron L, Antoniotti S, Lovisolo D (2004) Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med 8(2):161–168
Munoz-Espin D, Serrano M (2014) Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol 15(7):482–496
Nako Y, Shiozaki A, Ichikawa D, Komatsu S, Konishi H, Iitaka D et al (2012) Enhancement of the cytocidal effects of hypotonic solution using a chloride channel blocker in pancreatic cancer cells. Pancreatology 12(5):440–448
Ng EY, Sree SV, Ng KH, Kaw G (2008) The use of tissue electrical characteristics for breast cancer detection: a perspective review. Technol Cancer Res Treat 7(4):295–308
O’Grady SM, Lee SY (2005) Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int J Biochem Cell Biol 37(8):1578–1594
Ozkucur N, Perike S, Sharma P, Funk RH (2011) Persistent directional cell migration requires ion transport proteins as direction sensors and membrane potential differences in order to maintain directedness. BMC Cell Biol 12:4
Pardo LA (2004) Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 19:285–292
Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S et al (1999) Oncogenic potential of EAG K(+) channels. EMBO J 18(20):5540–5547
Parrasia S, Rossa A, Varanita T, Checchetto V, De Lorenzi R, Zoratti M et al (2021) An Angiopep2-PAPTP construct overcomes the blood-brain barrier. New perspectives against brain tumors. Pharmaceuticals (Basel) 14(2)
Pedemonte N, Galietta LJ (2014) Structure and function of TMEM16 proteins (anoctamins). Physiol Rev 94(2):419–459
Perez-Neut M, Shum A, Cuevas BD, Miller R, Gentile S (2015a) Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells. Oncotarget 6(3):1631–1639
Perez-Neut M, Rao VR, Haar L, Jones KW, Gentile S (2015b) Current and potential antiarrhythmic drugs targeting voltage-gated cardiac ion channels. Cardiol Pharmacol 4(139)
Perez-Neut M, Haar L, Rao V, Santha S, Lansu K, Rana B et al (2016a) Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma. Oncotarget 7(16):21991–22004
Perez-Neut M, Rao VR, Gentile S (2016b) hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism. Oncotarget 7(37):58893–58902
Peruzzo R, Mattarei A, Azzolini M, Becker-Flegler KA, Romio M, Rigoni G et al (2020) Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family. Redox Biol 37:101705
Planells-Cases R, Lutter D, Guyader C, Gerhards NM, Ullrich F, Elger DA et al (2015) Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs. EMBO J 34(24):2993–3008
Plummer HK 3rd, Dhar MS, Cekanova M, Schuller HM (2005) Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer 5:104
Rao VR, Perez-Neut M, Kaja S, Gentile S (2015) Voltage-gated ion channels in cancer cell proliferation. Cancers (Basel) 7(2):849–875
Ryland KE, Hawkins AG, Weisenberger DJ, Punj V, Borinstein SC, Laird PW et al (2016) Promoter methylation analysis reveals that KCNA5 ion channel silencing supports Ewing sarcoma cell proliferation. Mol Cancer Res 14(1):26–34
Schwab A, Wulf A, Schulz C, Kessler W, Nechyporuk-Zloy V, Romer M et al (2006) Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells. J Cell Physiol 206(1):86–94
Schwab A, Fabian A, Hanley PJ, Stock C (2012) Role of ion channels and transporters in cell migration. Physiol Rev 92(4):1865–1913
Serrano-Novillo C, Capera J, Colomer-Molera M, Condom E, Ferreres JC, Felipe A (2019) Implication of voltage-gated potassium channels in neoplastic cell proliferation. Cancers (Basel) 11(3)
Shennan DB (2008) Swelling-induced taurine transport: relationship with chloride channels, anion-exchangers and other swelling-activated transport pathways. Cell Physiol Biochem 21(1–3):15–28
Struski S, Doco-Fenzy M, Cornillet-Lefebvre P (2002) Compilation of published comparative genomic hybridization studies. Cancer Genet Cytogenet 135(1):63–90
Sui YJ, Sun MY, Wu F, Yang LF, Di WH, Zhang GZ et al (2014) Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells. Plos One 9(12)
Sun J, Chu Z, Moenter SM (2010) Diurnal in vivo and rapid in vitro effects of estradiol on voltage-gated calcium channels in gonadotropin-releasing hormone neurons. J Neurosci 30(11):3912–3923
Szabo I, Bock J, Jekle A, Soddemann M, Adams C, Lang F et al (2005) A novel potassium channel in lymphocyte mitochondria. J Biol Chem 280(13):12790–12798
Szabo I, Bock J, Grassme H, Soddemann M, Wilker B, Lang F et al (2008) Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci U S A 105(39):14861–14866
Szabo I, Soddemann M, Leanza L, Zoratti M, Gulbins E (2011) Single-point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosis. Cell Death Differ 18(3):427–438
Szabo I, Trentin L, Trimarco V, Semenzato G, Leanza L (2015) Biophysical characterization and expression analysis of Kv1.3 potassium channel in primary human leukemic B cells. Cell Physiol Biochem 37(3):965–978
Than BL, Goos JA, Sarver AL, O'Sullivan MG, Rod A, Starr TK et al (2014) The role of KCNQ1 in mouse and human gastrointestinal cancers. Oncogene 33(29):3861–3868
Tokuoka S, Morioka H (1957) The membrane potential of the human cancer and related cells. I Gan 48(4):353–354
Vallejo-Gracia A, Bielanska J, Hernandez-Losa J, Castellvi J, Ruiz-Marcellan MC, Ramon y Cajal S et al (2013) Emerging role for the voltage-dependent K+ channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy. J Leukoc Biol 94(4):779–789
Venturini E, Leanza L, Azzolini M, Kadow S, Mattarei A, Weller M et al (2017) Targeting the potassium channel Kv1.3 kills glioblastoma cells. Neurosignals 25(1):26–38
Villalonga N, Martinez-Marmol R, Roura-Ferrer M, David M, Valenzuela C, Soler C et al (2008) Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation. Biochim Biophys Acta 1783(5):728–736
Voss FK, Ullrich F, Munch J, Lazarow K, Lutter D, Mah N et al (2014) Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC. Science 344(6184):634–638
Wang Z (2004) Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 448(3):274–286
Wang XT, Nagaba Y, Cross HS, Wrba F, Zhang L, Guggino SE (2000) The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. Am J Pathol 157(5):1549–1562
Wang H, Zhang Y, Cao L, Han H, Wang J, Yang B et al (2002) HERG K+ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 62(17):4843–4848
Wang W, Gao Q, Yang M, Zhang X, Yu L, Lawas M et al (2015) Up-regulation of lysosomal TRPML1 channels is essential for lysosomal adaptation to nutrient starvation. Proc Natl Acad Sci U S A 112(11):E1373–E1381
Wei JF, Wei L, Zhou X, Lu ZY, Francis K, Hu XY et al (2008) Formation of Kv2.1-FAK complex as a mechanism of FAK activation, cell polarization and enhanced motility. J Cell Physiol 217(2):544–557
Wright SH (2004) Generation of resting membrane potential. Adv Physiol Educ 28(1–4):139–142
Wu H, Wang H, Guan S, Zhang J, Chen Q, Wang X et al (2017) Cell-specific regulation of proliferation by Ano1/TMEM16A in breast cancer with different ER, PR, and HER2 status. Oncotarget 8(49):84996–85013
Xu H, Ren D (2015) Lysosomal physiology. Annu Rev Physiol 77:57–80
Xu HX, Martinoia E, Szabo I (2015) Organellar channels and transporters. Cell Calcium 58(1):1–10
Yang B, Cao L, Liu B, McCaig CD, Pu J (2013) The transition from proliferation to differentiation in colorectal cancer is regulated by the calcium activated chloride channel A1. PLos One 8(4)
Yang H, Ma L, Wang Y, Zuo W, Li B, Yang Y et al (2018) Activation of ClC-3 chloride channel by 17beta-estradiol relies on the estrogen receptor alpha expression in breast cancer. J Cell Physiol 233(2):1071–1081
Zhang H, Li H, Liu E, Guang Y, Yang L, Mao J et al (2014) The AQP-3 water channel and the ClC-3 chloride channel coordinate the hypotonicity-induced swelling volume in nasopharyngeal carcinoma cells. Int J Biochem Cell Biol 57:96–107
Zheng F, Li H, Du W, Huang S (2009) Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation. Hematology 16(3):177–184
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Banderali, U., Leanza, L., Eskandari, N., Gentile, S. (2021). Potassium and Chloride Ion Channels in Cancer: A Novel Paradigm for Cancer Therapeutics. In: Stock, C., Pardo, L.A. (eds) Targets of Cancer Diagnosis and Treatment. Reviews of Physiology, Biochemistry and Pharmacology, vol 183. Springer, Cham. https://doi.org/10.1007/112_2021_62
Download citation
DOI: https://doi.org/10.1007/112_2021_62
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-03993-5
Online ISBN: 978-3-031-03994-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)